A carregar...
Evaluating When and Why Patients Discontinue Chronic Therapy for Irritable Bowel Syndrome With Constipation and Chronic Idiopathic Constipation
INTRODUCTION: To inform the patient-centered discussion regarding comparative outcomes with irritable bowel syndrome/chronic idiopathic constipation pharmacotherapy, we evaluated reasons and timing of discontinuation of FDA-approved pharmacotherapy for irritable bowel syndrome and chronic idiopathic...
Na minha lista:
| Publicado no: | Am J Gastroenterol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7565170/ https://ncbi.nlm.nih.gov/pubmed/32022721 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/ajg.0000000000000530 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|